JRCT ID: jRCTs031210002
Registered date:01/04/2021
Phase II study of concurrent intensity modulated radiation therapy with docetaxel, cisplatin and 5-FU for advanced squamous cell carcinoma of cervical esophagus in Japan
Basic Information
Recruitment status | Recruiting |
---|---|
Health condition(s) or Problem(s) studied | Esophageal cancer |
Date of first enrollment | 07/01/2022 |
Target sample size | 43 |
Countries of recruitment | |
Study type | Interventional |
Intervention(s) | protocol |
Outcome(s)
Primary Outcome | 3 year over-all survival |
---|---|
Secondary Outcome | protocol |
Key inclusion & exclusion criteria
Age minimum | Not applicable |
---|---|
Age maximum | Not applicable |
Gender | Both |
Include criteria | protocol |
Exclude criteria | protocol |
Related Information
Primary Sponsor | Watanabe Akinori |
---|---|
Secondary Sponsor | |
Source(s) of Monetary Support | |
Secondary ID(s) |
Contact
Public contact | |
Name | Akinori Watanabe |
Address | 1-15-1, Kitazato, Minami-ku, Sagamihara-shi Kanagawa Kanagawa Japan 252-0374 |
Telephone | +81-42-778-8111 |
akinori@kitasato-u.ac.jp | |
Affiliation | Kitasato university Hospital |
Scientific contact | |
Name | Akinori Watanabe |
Address | 1-15-1, Kitazato, Minami-ku, Sagamihara-shi Kanagawa Kanagawa Japan 252-0374 |
Telephone | +81-42-778-8111 |
akinori@kitasato-u.ac.jp | |
Affiliation | Kitasato university Hospital |